HO
Hemogenyx Pharmaceuticals Plc
HOPHF · OTC
$2.33 +0.00% (+$0.00)
Market Cap £11.7M
P/E Ratio -
Div. Yield -
ROE 838.45%
Bulios Fair Price
$1.72
26.2% downside
Trenutna cena
$2.33
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HOPHF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.79x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 28.54%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 221.69%
ROE 838.45%
Asset turnover 0.00x
Debt
28 /100
High Debt/Equity 1.68x
Current ratio 1.38x
Int. coverage -41.55x
Stability
41 /100
Moderate Beta 1.53x
EPS volatility 29.48%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HOPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vladislav Sandler
Employees
16
Headquarters
London